News Roche keeps Rituxan evergreen with Breakthrough designation,... Roche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Ri
News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News Roche breast cancer trial success could kill Puma's rival Perjeta trial success sends rival biotech's share price crashing.
News Patient death raises concerns over Roche haemophilia drug Concerns following event on HAVEN1 trial.
News FDA kicks off review of Takeda's narcolepsy hopeful The FDA has started a priority review of Takeda's oveporexton for sleep disorder narcolepsy, setting up a decision in the third quarter of the year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
